Teladoc Health, Inc. TDOC
We take great care to ensure that the data presented and summarized in this overview for Teladoc Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TDOC
View all-
Black Rock Inc. New York, NY21.6MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.8MShares$135 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.55MShares$44.6 Million0.08% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.51MShares$44.3 Million0.13% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.05MShares$34.4 Million0.01% of portfolio
-
State Street Corp Boston, MA5.01MShares$34.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.07MShares$27.7 Million0.0% of portfolio
-
Maple Rock Capital Partners Inc. Toronto, A63.35MShares$22.8 Million1.03% of portfolio
-
Goldman Sachs Group Inc New York, NY2.86MShares$19.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.85MShares$19.4 Million0.0% of portfolio
Latest Institutional Activity in TDOC
Top Purchases
Top Sells
About TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Insider Transactions at TDOC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2025
|
David L Shedlarz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,467
+35.11%
|
-
|
|
May 21
2025
|
David B Snow Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,467
+17.21%
|
-
|
|
May 21
2025
|
Catherine Jacobson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,467
+31.57%
|
-
|
|
May 21
2025
|
Thomas Mckinley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,467
+23.6%
|
-
|
|
Apr 07
2025
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,494
-5.81%
|
$44,964
$6.81 P/Share
|
|
Apr 04
2025
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,652
+8.93%
|
-
|
|
Mar 28
2025
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
4,418
+7.27%
|
-
|
|
Mar 21
2025
|
Fernando M. Rodrigues President of BetterHelp |
SELL
Open market or private sale
|
Direct |
2,663
-100.0%
|
$21,304
$8.0 P/Share
|
|
Mar 20
2025
|
Fernando M. Rodrigues President of BetterHelp |
SELL
Open market or private sale
|
Direct |
1,503
-36.08%
|
$12,024
$8.42 P/Share
|
|
Mar 20
2025
|
Jason Eric Evans Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,016
+14.28%
|
-
|
|
Mar 20
2025
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
11,011
-14.62%
|
$88,088
$8.42 P/Share
|
|
Mar 20
2025
|
Mala Murthy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,586
-15.04%
|
$164,688
$8.42 P/Share
|
|
Mar 20
2025
|
Carlos Nueno President, International |
SELL
Open market or private sale
|
Direct |
8,266
-39.07%
|
$66,128
$8.42 P/Share
|
|
Mar 20
2025
|
Kelly Bliss President, U.S. Group Health |
SELL
Open market or private sale
|
Direct |
9,470
-17.26%
|
$75,760
$8.42 P/Share
|
|
Mar 19
2025
|
Fernando M. Rodrigues President of BetterHelp |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+50.0%
|
-
|
|
Mar 19
2025
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
21,400
+22.13%
|
-
|
|
Mar 19
2025
|
Mala Murthy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
36,933
+21.25%
|
-
|
|
Mar 19
2025
|
Carlos Nueno President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
18,225
+46.28%
|
-
|
|
Mar 19
2025
|
Kelly Bliss President, U.S. Group Health |
BUY
Exercise of conversion of derivative security
|
Direct |
19,433
+26.16%
|
-
|
|
Mar 05
2025
|
Fernando M. Rodrigues President of BetterHelp |
SELL
Open market or private sale
|
Direct |
3,558
-100.0%
|
$32,022
$9.2 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 19K shares |
|---|---|
| Exercise of conversion of derivative security | 447K shares |
| Grant, award, or other acquisition | 17.5K shares |
| Open market or private sale | 248K shares |
|---|